Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients.

ABSTRACT:

SUBMITTER: Jan MY 

PROVIDER: S-EPMC8233547 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature